Search by Drug Name or NDC

NDC 57841-1200-01 Aemcolo 194 mg/1 Details

Aemcolo 194 mg/1

Aemcolo is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RedHill Biopharma Ltd. The primary component is RIFAMYCIN.

MedlinePlus Drug Summary

Rifamycin is used to treat of travelers' diarrhea caused by certain bacteria. Rifamycin is in a class of medications called antibiotics. It works by stopping the growth of the bacteria that cause diarrhea. Antibiotics such as rifamycin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Related Packages: 57841-1200-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rifamycin

Product Information

NDC	57841-1200
Product ID	57841-1200_9377a845-abf1-4c32-84e6-51ee3473c9d2
Associated GPIs	16000048200620
GCN Sequence Number	079335
GCN Sequence Number Description	rifamycin sodium TABLET DR 194 MG ORAL
HIC3	W9C
HIC3 Description	RIFAMYCINS AND RELATED DERIVATIVE ANTIBIOTICS
GCN	45823
HICL Sequence Number	011697
HICL Sequence Number Description	RIFAMYCIN SODIUM
Brand/Generic	Brand
Proprietary Name	Aemcolo
Proprietary Name Suffix	n/a
Non-Proprietary Name	Rifamycin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, DELAYED RELEASE
Route	ORAL
Active Ingredient Strength	194
Active Ingredient Units	mg/1
Substance Name	RIFAMYCIN
Labeler Name	RedHill Biopharma Ltd
Pharmaceutical Class	Rifamycin Antibacterial [EPC], Rifamycins [CS]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA210910
Listing Certified Through	2024-12-31

Package

NDC 57841-1200-01 (57841120001)

Pricing Information	N/A
NDC Package Code	57841-1200-1
Billing NDC	57841120001
Package	2 BLISTER PACK in 1 CARTON (57841-1200-1) / 6 TABLET, DELAYED RELEASE in 1 BLISTER PACK (57841-1200-0)
Marketing Start Date	2021-07-01
NDC Exclude Flag	N